Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder
mSystems · 16.05.2024 · 9 (5)
DOI: 10.1128/msystems.00503-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, erschienen am 16.05.2024. Verfasst von Joann Phan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sun Genomics, Inc., San Diego, California, USA. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Gastrointestinal Microbiome, Synbiotics. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The efficacy of prebiotics and probiotics (synbiotics when combined) to improve symptoms associated with autism spectrum disorder (ASD) has shown considerable inter-study variation, likely due to the complex, heterogeneous nature of the disorder and its associated behavioral, developmental, and gastrointestinal symptoms. Here, we present a precision synbiotic supplementation study in 296 children and adults diagnosed with ASD versus 123 age-matched neurotypical controls. One hundred seventy ASD participants completed the study. Baseline and post-synbiotic assessment of ASD and gastrointestinal (GI) symptoms and deep metagenomic sequencing were performed. Within the ASD cohort, there were significant differences in microbes between subpopulations based on the social responsiveness scale (SRS2) survey ( Prevotella spp. , Bacteroides, Fusicatenibacter , and others) and gluten and dairy-free diets ( Bifidobacterium spp., Lactococcus, Streptococcus spp., and others). At the baseline, the ASD cohort maintained a lower taxonomic alpha diversity and significant differences in taxonomic composition, metabolic pathways, and gene families, with a greater proportion of potential pathogens, including Shigella, Klebsiella, and Clostridium, and lower proportions of beneficial microbes, including Faecalibacterium compared to controls. Following the 3-month synbiotic supplementation, the ASD cohort showed increased taxonomic alpha diversity, shifts in taxonomy and metabolic pathway potential, and improvements in some ASD-related symptoms, including a significant reduction in GI discomfort and overall improved language, comprehension, cognition, thinking, and speech. However, the open-label study design may include some placebo effects. In summary, we found that precision synbiotics modulated the gut microbiome and could be used as supplementation to improve gastrointestinal and ASD-related symptoms. IMPORTANCE Autism spectrum disorder (ASD) is prevalent in 1 out of 36 children in the United States and contributes to health, financial, and psychological burdens. Attempts to identify a gut microbiome signature of ASD have produced varied results. The limited pre-clinical and clinical population sizes have hampered the success of these trials. To understand the microbiome associated with ASD, we employed whole metagenomic shotgun sequencing to classify microbial composition and genetic functional potential. Despite being one of the most extensive ASD post-synbiotic assessment studies, the results highlight the complexity of performing such a case–control supplementation study in this population and the potential for a future therapeutic approach in ASD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sun Genomics, Inc., San Diego, California, USA.
- Department of Civil Engineering, Construction Management, and Environmental Engineering, Northern Arizona University, Flagstaff, Arizona, USA.
- Biodesign Center for Health Through Microbiomes, Arizona State University, Tempe, Arizona, USA.
ORCID-Profile: Joann Phan, James Adams, Rosa Krajmalnik-Brown
Zitieren
APA
Phan, J., Calvo, D. C., Nair, D., Jain, S., Montagne, T., Dietsche, S., Blanchard, K., Treadwell, S., Adams, J., & Krajmalnik-Brown, R. (2024). Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder. mSystems, 9(5). https://doi.org/10.1128/msystems.00503-24
Vancouver
Phan J, Calvo DC, Nair D, Jain S, Montagne T, Dietsche S, et al. Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder. mSystems. 2024;9(5). doi:10.1128/msystems.00503-24
BibTeX
@article{Phan2024,
author = {Phan, Joann and Calvo, Diana C and Nair, Divya and Jain, Suneer and Montagne, Thibaut and Dietsche, Summer and Blanchard, Kelsey and Treadwell, Shirin and Adams, James and Krajmalnik-Brown, Rosa},
title = {Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder},
journal = {mSystems},
year = {2024},
volume = {9},
number = {5},
doi = {10.1128/msystems.00503-24}
}
EUVIMED